Global Open
Innovation
Challenge
We're searching the globe for the most innovative biotech startups ready to shape the future of medicine — in partnership with CELLTRION, one of Asia's leading biopharmaceutical companies.
Mar – May 2026
The Green Ticket Program
A three-stage open innovation funnel connecting the world's most promising biotech startups with CELLTRION — Asia's leading biopharmaceutical company.
CELLTRION's Technology Focus
CELLTRION is actively seeking partnerships across four strategic technology domains that align with its global biopharmaceutical pipeline.
- ADC technology & payloads
- Bispecific / multispecific antibodies
- Novel targeted immuno-oncology
- Autoimmune & metabolic drugs
- mRNA platforms & LNP delivery
- Cell & gene therapy (CAR-T/NK)
- Microbiome-based therapeutics
- Targeted protein degradation
- AI-driven drug discovery
- Digital therapeutics (DTx)
- Wearables & smart diagnostics
- Medical big data analytics
- Oral delivery for antibodies
- Long-acting injectables
- Patch / microneedle formulations
- Smart self-injection devices
2026 Timeline
- Online applications open globally
- Company profile + IR deck submission
- Fundraising info required
- Document & pitch screening
- Pre-PoC feasibility check
- Top 5 PoC Partners selected
- Type-based PoC execution (5 cos.)
- KPI-based milestone verification
- Mid-point review → shortlist to 3
- Pharma-Bio Investment Convention
- 5 finalists pitch live
- 3 winners selected & prizes awarded
- CELLTRION follow-up OI confirmed
How the PoC Works
Top 5 selected companies run a structured, results-focused Proof-of-Concept program in direct collaboration with CELLTRION's research teams.
Benefits & Prizes
All 5 finalists and 3 final winners receive a comprehensive package of prizes, partnerships, and pathways into the Korean and global pharma market.
Get Your Green Ticket
Your Green Ticket awaits.